NO952854L - 1-arylpyrimidin-derivater - Google Patents

1-arylpyrimidin-derivater

Info

Publication number
NO952854L
NO952854L NO952854A NO952854A NO952854L NO 952854 L NO952854 L NO 952854L NO 952854 A NO952854 A NO 952854A NO 952854 A NO952854 A NO 952854A NO 952854 L NO952854 L NO 952854L
Authority
NO
Norway
Prior art keywords
oxo
together form
substituted
methylcyclohexyl
pyran
Prior art date
Application number
NO952854A
Other languages
English (en)
Other versions
NO952854D0 (no
Inventor
Yoshiaki Isobe
Junko Umezawa
Yuso Goto
Masashi Sasaki
Nobuo Watanabe
Hideharu Sato
Fumihiro Obara
Toshimasa Katagiri
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO952854D0 publication Critical patent/NO952854D0/no
Publication of NO952854L publication Critical patent/NO952854L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører 1-arylpyrimidin- derivater representert ved den generelle formel (I): d) Ar R6 ., R5 hvori Rj^ er H, alkyl eller aralkyl; Ar er 1-naftyl, eller en substituert eller usubstituert fenylgruppe; R4 er en substituert fenyl, en substituert styryl, 1- metylcykloheksyl, 4-metylcykloheksyl, 4-okso-4H-pyran-2- yl eller 2-okso-2H-pyran-5-yl-gruppe; R5 °9 Re nver uavhengig er H eller alkyl; R3 er H, og R7 og R8 utgjør sammen okso, eller R3 og R7 utgjør sammen en direkte binding, og R5 og R8 utgjør sammen en annen direkte binding, eller farmasøytisk akseptable salter derav; og anvendelser av slike forbindelser som midler for behandling av allergiske sykdommer.
NO952854A 1994-07-19 1995-07-18 1-arylpyrimidin-derivater NO952854L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16722294 1994-07-19
JP19421994 1994-08-18

Publications (2)

Publication Number Publication Date
NO952854D0 NO952854D0 (no) 1995-07-18
NO952854L true NO952854L (no) 1996-01-22

Family

ID=26491330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952854A NO952854L (no) 1994-07-19 1995-07-18 1-arylpyrimidin-derivater

Country Status (7)

Country Link
US (1) US5661153A (no)
EP (1) EP0700908A1 (no)
AU (1) AU681034B2 (no)
CA (1) CA2154293A1 (no)
FI (1) FI953479A (no)
NO (1) NO952854L (no)
NZ (1) NZ272591A (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US5821247A (en) * 1996-09-19 1998-10-13 Japan Energy Corporation Hydroquinone derivative and pharmaceutical use thereof
AU6320998A (en) 1997-02-21 1998-09-09 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
WO2000029389A1 (fr) * 1998-11-18 2000-05-25 Elena Alexandrovna Izaxon 6-(3-carboxymethylphenyl)-amino-uracyle ayant une action biologique
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7427606B2 (en) 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
US6670334B2 (en) 2001-01-05 2003-12-30 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
CA2460911C (en) 2001-10-01 2011-08-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
TW200402291A (en) * 2002-06-06 2004-02-16 Inst Med Molecular Design Inc Antiallergic
JPWO2004026842A1 (ja) * 2002-09-20 2006-01-12 住友製薬株式会社 新規ウラシル誘導体及びその医薬用途
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
KR20070007104A (ko) * 2004-02-18 2007-01-12 아스트라제네카 아베 화합물
EP2048137A1 (en) * 2004-02-18 2009-04-15 AstraZeneca AB Benzamide derivatives and their use as glucokinase activating agents.
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
US7442687B2 (en) 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7605143B2 (en) 2004-08-02 2009-10-20 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
WO2006028618A1 (en) 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
CA2581619A1 (en) 2004-10-16 2006-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
GB0423044D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
US20110059941A1 (en) * 2005-05-24 2011-03-10 Peter William Rodney Caulkett 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
BRPI0622262A2 (pt) * 2005-07-09 2011-08-09 Astrazeneca Ab composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
US20110053910A1 (en) * 2005-07-09 2011-03-03 Mckerrecher Darren 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
EP2027113A1 (en) * 2005-07-09 2009-02-25 AstraZeneca AB Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
TW200738621A (en) * 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
WO2007120972A2 (en) 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
TW200825060A (en) * 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
WO2008075073A1 (en) * 2006-12-21 2008-06-26 Astrazeneca Ab Novel crystalline compound useful as glk activator
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
WO2010015849A2 (en) 2008-08-04 2010-02-11 Astrazeneca Ab Therapeutic agents 414
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5251395A (en) * 1975-10-21 1977-04-25 Yamanouchi Pharmaceut Co Ltd Preparation of novel pteridine derivaties
JPS5283800A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd Novel pteridine derivative
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
US4452788A (en) * 1982-04-21 1984-06-05 Warner-Lambert Company Substituted 8-phenylxanthines
FR2531085A1 (fr) * 1982-07-28 1984-02-03 Adir Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
IT1240843B (it) * 1990-05-24 1993-12-17 Malesci Istituto Farmacobiologico Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione.
IL98559A0 (en) * 1990-06-21 1992-07-15 Schering Corp Polycyclic guanine derivatives
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
JPH05194424A (ja) 1991-10-09 1993-08-03 Nikko Kyodo Co Ltd 新規なピリミジン誘導体及び該誘導体を有効成分とする医薬
JPH06135943A (ja) 1992-09-14 1994-05-17 Japan Energy Corp 新規なウラシル誘導体及びそれを有効成分とするアレルギー疾患治療薬

Also Published As

Publication number Publication date
NO952854D0 (no) 1995-07-18
EP0700908A1 (en) 1996-03-13
FI953479A0 (fi) 1995-07-18
AU2505795A (en) 1996-02-01
AU681034B2 (en) 1997-08-14
US5661153A (en) 1997-08-26
NZ272591A (en) 1997-05-26
CA2154293A1 (en) 1996-01-20
FI953479A (fi) 1996-01-20

Similar Documents

Publication Publication Date Title
NO952854L (no) 1-arylpyrimidin-derivater
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
DK0696281T3 (da) Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater
NO985864L (no) Nye anti-virale forbindelser
AU591860B2 (en) Pyrolidineamide derivative having anti-prolyl endopeptidase
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2336412A1 (en) Medicament for treatment of diabetes
AU1400801A (en) Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
NO971384L (no) Pyrimidinylpyrazol-derivat
CA2168937A1 (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
DE69116237D1 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
CA2093630A1 (en) Pyrroloazepine compound
ES2102295B1 (es) Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
CA2092919A1 (en) Epoxysuccinamic acid derivatives
DK0913151T3 (da) Anti-helicobacter Pylori-præparater indeholdende 1-methylcarbapenemderivater som den aktive bestanddel
EA200500032A1 (ru) Производные ацилоксипирролидина и их применение в качестве лигандов v1b или v1b и v1a рецепторов
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
NO951650L (no) Forebyggende middel mot blodplateaggregering
NO933691L (no) Tiokarbamatsulfoksydsammensetning for avholdenhet fra inntakelse av etanol
SE9402596D0 (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa
MY101628A (en) Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them.
RU94033470A (ru) Циклогексановые производные, фармкомпозиция на их основе и способ лечения
DE69622393D1 (de) Neue verwendung von pyrazolopyridinverbindungen